Form EFFECT KalVista Pharmaceuticals

June 17, 2026 6:03 AM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 16, 2026

Accession Number:

0001193125-26-267506

Submission Type:

POS AM

CIK:	0001348911
Company Name:	KalVista Pharmaceuticals, Inc.
File Number:	333-280759

StreetInsider